These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17237556)

  • 1. Immunizations for HIV-infected adults: indications, timing, and response.
    Spach DH
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
    Valencia Ortega ME; González Lahoz JM
    An Med Interna; 1998 Aug; 15(8):439-42. PubMed ID: 9780428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination guidelines for female infertility patients.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S169-71. PubMed ID: 19007619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunization in HIV-infected patients.
    Pau AK; McNicholl IR; Pursell KJ
    Pharmacotherapy; 1996; 16(2):163-70. PubMed ID: 8820461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines: more reasons to immunize.
    Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults.
    Molton J; Smith C; Chaytor S; Maple P; Brown K; Johnson M; Geretti AM
    J Infect; 2010 Jul; 61(1):73-80. PubMed ID: 20403382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003.
    Teshale EH; Hanson D; Flannery B; Phares C; Wolfe M; Schuchat A; Sullivan P
    Vaccine; 2008 Oct; 26(46):5830-4. PubMed ID: 18786586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have your vaccinations had a check-up lately? Don't assume vaccinations received during childhood will protect you for the rest of your life.
    Harv Womens Health Watch; 2009 Feb; 16(6):6-7. PubMed ID: 19297746
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
    Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
    Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keeping up with your vaccinations. New guidelines include several changes.
    Harv Womens Health Watch; 2011 Apr; 18(8):2-3. PubMed ID: 21544972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
    Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
    AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing vaccines: defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection.
    Quinn KJ; McCarty EJ; Quah SP; Emerson CR; Donnelly CM
    Int J STD AIDS; 2012 Feb; 23(2):136-7. PubMed ID: 22422690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks and benefits of influenza and pneumococcal immunization in HIV-1 infected individuals].
    Tanzi E; Amendola A; Zappa A; Pariani E; Monguzzi A; Colzani D
    Ann Ig; 2003; 15(5):567-73. PubMed ID: 14969311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV testing: rationale for changing recommendations.
    Janssen RS
    Top HIV Med; 2007; 15(1):6-10. PubMed ID: 17406078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 20. Routine immunization in HIV: helpful or harmful?
    Sax P; Singer M
    AIDS Clin Care; 1996 Feb; 8(2):11-3, 15. PubMed ID: 11363059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.